Generic Medicines Working Group (GMWG) Communique - 26 February 2016
Page last updated: 21 April 2016
The third meeting of the GMWG was held in Canberra on 26 February 2016.
Attendees
Attendees included Mr Mike Healy, who acted as co-Chair in Mr Allan Tillack’s absence, and Mr Andrew Stuart, Deputy Secretary, Department of Health. Representatives of the Generic and Biosimilar Medicines Association (GBMA), and the Department of Health were also in attendance.
Purpose
The meeting was an opportunity for the GMWG to formally endorse the work plans for the four sub-groups, and to hear a presentation from GBMA on costs involved in operating in the generic medicines market.
Outcomes
GMWG formally endorsed the work plans for the four sub-groups, and agreed to explore issues raised in the GBMA presentation through the Pricing Policy, Supply and Viability sub-group.
Next steps
The Department of Health agreed to develop a summary of the work plans for public release, and the sub-groups will progress the four policy priorities at face-to-face meetings later in March 2016. This will include further discussion of the issues raised as part of GBMA’s presentation.
The next GMWG meeting is scheduled for June 2016.
